Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-06

FDA Approved: FLUOROURACIL — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Fluorouracil from Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)

Snippet

SUPPL AP for FLUOROURACIL (FLUOROURACIL)